Case finding: The missing link in chronic disease management

Canadian Pharmacists Journal

Volumn 144, Issue 4, 2011, Pages 170-171

  Kassamali, Aliya ^a   Houle, Sherilyn ^b   Rosenthal, Meagen ^b   Tsuyuki, Ross T ^b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE FINDING; CHRONIC DISEASE; HUMAN; PHARMACY; PREVALENCE; RISK FACTOR;

EID: 79960867608     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.3821/1913-701X-144.4.170     Document Type: Article

References (11)

1. Canadian Pharmacists Association. Blueprint for Pharmacy. Available: www.pharmacists.ca (accessed November 7, 2010).
2. Peytremann-Brivevaux I, Burnand B. Disease management: a proposal for a new definition. Int J Integr Care 2009;9:e16.
3. Tsuyuki RT, Johnson JA, Teo KK, et al. Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk. Ann Pharmacotherapy 1999;33(9):910-919.
4. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists - Hypertension (SCRIP-HTN). Arch Intern Med 2008;168(21):2355-2361.
5. Koshman SL, Charrois TL, Simpson SH, et al. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 2008;168(7):687-694.
6. Public Health Agency of Canada. Report from the Canadian Chronic Disease Surveillance System: Hypertension in Canada, 2010. Available: www.phac-aspc.gc.ca/cd-mc/cvd-mcv/ccdsssnsmc-2010/index-eng.php (accessed June 21, 2011).
7. Joffres MR, Hamet P, MacLean DR, et al. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001;14:1099-1105.
8. Hensrud DD. Clinical preventative medicine in primary care: background and practice: 3. Delivering preventive screening services. Mayo Clin Proc 2000;75:381-385.
9. Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J 2010;143:37-42.
10. Farahani P, Levine M, Gaebel K, et al. Exploring patient demographic and clinical characteristics associated with lipidlowering pharmacotherapy use in primary care. Clin Invest Med 2007;30(2):E63-E69.
11. Leenan FHH, Dumais J, McInnis NH, et al. Results of the Ontario Survey on the Prevalence and Control of Hypertension. CMAJ 2008;178(11):1441-1449.